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MEDICARE
The Medicare Managed
Care Choice
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careful evaluation
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professional
overview highlight
of the most imr
By Journa
ed care eicare n November 1998,Mei
care beneficiaries around
ns and the country received a
seven-page bulletin "Medi-
is criti- care and You" from the
Department of Health and
a pro- Human Services (DHHS) appris-
ing them of their opportunity to
nment choose managed care in lieu of
traditional Part A/Part B cover-
viding age. The initiative comes in
reated response to the 1997 enactmentof Medicare+Choice (the long
nanticipated "Medicare Part C"),n andbut attempts to deal with current
om the service options.Somewhat belated for some
s.This beneficiaries, the one-size-fits-all
5. notice was sharply criticized for
s some failure to emphasize that nos somechange is required. In fact, the
ortant catalog of options is not avail-able to Medicare beneficiaries in
issues. many localities, mostly rural
areas, where no provider has
I Staff signed a contract with DHHS to
provide specific expanded ser-
vices. Indeed, some areas still
have no Medicare HMO at all.
Furthen it does not clearly state
that a beneficiary who chooses
Medicare managed care gives up
traditional coverage.
Elder law attorneys heard
from their clients-or proactive-
ly sent a reassuring explanation:
No change is necessary. Change
may not be wise for many. The
reasons have to do with man-
aged care generally and with
Medicare managed care in par-
ticular.
The Track Record for
Medicare Managed Care
The federal government was an
innovator in managed care in the
early eighties, anticipating the
growing use of cost constraints
and prospective payments in
employee benefits. The model
came too little and too early,
however. Contracting providers
were restricted from offering
many of the benefits beneficia-
ries wished Medicare provided,
such a prescription drug cover-
age, and administrative require-
ments were daunting for the era.
In addition, some HMOs-espe-
cially in sunbelt locations, which
held the lure of a great volume
of patients-engaged in wide-
spread fraud, signing up reluc-
tant people on the street, main-
taining enrollees on the records
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after their deaths, and even
enrolling individuals listed in the
obituaries. Perhaps more impor-
tant for current times, more rep-
utable providers found profits
elusive and dropped out. The
proportion of Medicare man-
aged care enrollees topped out at
less than 4 percent, and the gov-
ernment withdrew its support
for the concept.
Medicare HMOs have a
renewed impetus in the mid-
1990s. Managed care providers
who enjoyed their growth in the
private employee benefits mar-
ket have looked to Medicare for
new markets. Current contracts
are similar to private sector con-
tracts in that they provide for a
set fee per beneficiary per
month, thereby spreading the
risk of the need for high-cost
care to the provider organiza-
tion. By mid 1998, about 16 per-
cent of Medicare beneficiaries
had opted for HMO coverage,
and the number is growing as
new providers and regions offer
the option. Managed care pro-
vides federal policy analysts with
the hope of controlling and
accurately predicting costs in
order to keep the Hospital
Insurance Trust Fund solvent
and contain Part B premiums
and the need for general rev-
enues subsidies.
Why Join a Medicare HMO?
Medicare beneficiaries who
choose HMO care generally
receive a broader package of
benefits than are provided by
traditional Part A and B cover-
age, including such preventive
care services as routine physi-
cals, eye and hearing exams, and
immunizations. Over half of
HMOs offer some coverage for
prescription drugs for an option-
al premium. Prescription drug
costs is the most frequently cited
reason clients switch to HMO
coverage.
Beneficiaries pay the Part B
premium and possibly a sur-
charge to the HMO for costly
extra benefits. However, care
management is expected to
lower the cost of the total pack-
age of benefits and eliminates
the need for Medigap insurance.
Medicare HMOs do not, howev-
er, provide long-term care.
The Potential Betrayal of
HMO Coverage for the
Elderly
Two principal problems loom
ahead for some Medicare benefi-
ciaries. Both are based in the
managed care cost-containment
strategy: shifting the risk of
high-cost care to the provider,
who must take steps to control
the utilization of high-cost ser-
vices or become unprofitable.
Among the care management
strategies common to HMOs,
three are significant impedi-
ments to good care for elders.
Geographic Restrictions
Most HMOs require that benefi-
ciaries receive all care except
emergency services from desig-
nated providers in the region.
The pattern is essential to pro-
jections for the profile of poten-
tial enrollees and to negotiating
contracts with providers that
assure a "captive market" of
patients. Only a limited number
of providers have attempted the
difficulties of serving the consid-
erable population that migrates
by season. Thus, an HMO is sel-
dom appropriate for "snow-
bird" migrating retirees.
Similarly, frequent travelers
will have significant problems
with coverage if an enrollee
becomes ill while away from
home. All HMOs are required to
cover emergency care provided
anywhere by any appropriate
and qualified provider, but man-
aged care organizations have
placed prior approval road
blocks that, at best, delay the
delivery of care. Recent federal
legislation has been enacted to
require that all HMOs apply the
"prudent layman rule" with
regard to payments for emer-
gency care at home or elsewhere,
but no track record of compli-
ance assures the individual
patient will benefit consistently.
Specialist Care and Chronic
Illness
Most managed care providers
require patients to undergo
screening by a primary care
provider or other "gatekeeper"
before receiving care from a spe-
cialist. Such gatekeeping is very
burdensome for a patient with a
chronic condition and may
result in inappropriate care if
specialist services are denied. For
example, an individual with
severe rheumatoid arthritis
might be approved to consult a
specialist for pain and care of the
specific condition. Given that
chronic conditions often affect
the individual's overall health
and response to treatment, use-
ful specialist care might be
denied when the patient seeks
treatment for an ordinary illness
such as the flu. The primary care
provider might not appropriate-
ly take into account the severity
of and the impact of treatment
for the chronic condition and
provide ineffective or harmful
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care for the transitory condition.
Only a few HMOs have provi-
sions for recognizing patients
with compromising chronic con-
ditions as eligible to receive all
care from a designated specialist.
Beneficiaries who travel fre-
quently or regularly, or who have
ongoing needs for specialist care
are well advised to stick with tra-
ditional Medicare coverage.
Prescription Drug Restrictions
Many HMOs have arrangements
with drug companies to utilize
specific, sometimes generic,
forms of drugs. Though such
drugs are generally considered to
be equivalents, many people
experience great differences in
drug potency or side effects. Side
effects and dosages are very
important to elderly and ill bene-
ficiaries. If the patient must have
a drug the HMO does not gener-
ally provide, the patient's cost
and/or hassle factor increases.
In a few states, HMOs are
required to provide an adminis-
trative process by which physi-
cians can request drugs not on
the approved list for patients
who need them. However, all
such legislation is quite new, and
its effectiveness is untested.
Other Problems Affecting
Continuity of Coverage
Underestimating the Cost of
Care
Often, initial premiums are set
too low for pay costs. Upon
entering the Medicare market,
most HMOs set premiums lower
than projected costs to attract
enrollees. The failure of HMOs
in 1998 is due at least in part to
the very low premiums charged
to enter the market. At the least,
enrollees face a rise in premiums
in the first five years. At worst,
the HMO will withdraw from
the market leaving enrollees to
readjust to traditional Parts A
and B. Premiums no higher than
the Part B premium are suspect,
since the HMO bears the risk
(generally about 30 percent of
costs) borne by the government
with traditional Medicare cover-
age. Coverage with prescription
benefits and preventive care
require premiums exceeding
$125 per month in 1998.
The HMO Withdraws from the
Market
A number of HMOs cannot
make a profit in the Medicare
market, as shown by the first
wave of withdrawals from con-
tracts on January 1, 1999. The
providers most likely to end
Medicare coverage are in rural
areas where there are too many
Medicare enrollees and too few
younger and healthier individu-
als. Those who set the initial pre-
mium too low are also at risk.
Beneficiaries can return to
traditional coverage if their
HMO is no longer available.
However, beneficiaries with sig-
nificant needs particularly for
prescription drugs usually can-
not restore their Medigap cover-
age with drug coverage.
Medicare HMO beneficia-
ries are entitled to receive
Medigap coverage, but are
restricted to certain basic poli-
cies that do not include drugs.
Insurers can deny other cover-
age or require payment of very
high premiums.
Generally, any beneficiary is
well advised to maintain
Medigap coverage during the
first interactions with a new
HMO provider. It is far more
difficult to predict the time the
HMO may end its contract. It is
better to anticipate the potential-
ly unstable HMO contract and
forego HMO coverage unless
there are strong indicators that
the HMO is a long-term and
successful participant in health
care in the area.
The Future of Medicare's
Managed Care Choices
The federal government is test-
ing the expansion of managed
care, and information about
managed care, in five states:
Arizona, Florida, Ohio, Oregon,
and Washington, where benefi-
ciaries have received the 36-page
book that expands on managed
care and Medicare+Choice. The
book has attracted criticisms
similar to those of the nation-
wide bulletin and will be revised.
Meanwhile, insurance compa-
nies and advocates are sending
out information representing
their own perspectives.
